113261-00-0

Usage

Uses

Used in Organic Synthesis:
(3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER is used as a synthetic intermediate for the creation of various organic compounds. Its benzyl ester and amino-phenyl groups provide opportunities for chemical reactions and modifications, facilitating the synthesis of a range of products.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, (3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER may serve as a building block or a precursor for the development of pharmaceuticals. Its specific functional groups could be leveraged to design and synthesize new drug candidates with potential therapeutic applications.
Used in Research and Development:
(3-AMINO-PHENYL)-CARBAMIC ACID BENZYL ESTER is utilized in research and development settings to study its chemical properties, reactivity, and potential interactions with biological systems. This knowledge can contribute to the advancement of scientific understanding and the discovery of new applications in various industries.

Upstream product

• 108-45-2 m-phenylenediamine 
• 501-53-1 benzyl chloroformate 
• 53821-16-2 (3-nitrophenyl)carbamic acid benzyl ester 
• 1885-14-9 phenyl chloroformate 

Downstream Products

• 908248-23-7 benzyl 3-formylquinolin-7-ylcarbamate 
• 1604811-22-4 (E)-N-(3-(5-chloro-4-(1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-4-(4-(dimethylamino)but-2-enamido)-N-methylbenzamide 
• 1604811-96-2 4-amino-N-(3-(5-chloro-4-(1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-N-methylbenzamide 
• 1604811-94-0 4-amino-N-(3-(5-chloro-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-N-methylbenzamide 
• 1604811-92-8 tert-butyl 4-((3-(5-chloro-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)(methyl)carbamoyl)phenylcarbamate 
• 1604811-88-2 benzyl N-{3-[N-methyl(4-{[(tert-butoxy)carbonyl]amino}benzene)amido]phenyl}carbamate 
• 1604811-85-9 benzyl 3-(methylamino)phenylcarbamate 
• 1604811-82-6 benzyl 3-(2,2,2-trifluoro-N-methylacetamido)phenylcarbamate 
• 1604811-19-9 (E)-N-(3-(5-chloro-4-(1H-indol-3-yl)pyridin-2-ylamino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide 
• 1604811-67-7 tert-butyl 4-(3-(5-chloro-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyridin-2-ylamino)phenylcarbamoyl)phenylcarbamate 
• 1604811-18-8 (E)-N-(3-(5-cyano-4-(1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide 
• 1604811-63-3 (E)-N-(3-(5-cyano-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)-4-(4-(dimethylamino)but-2-enamido)benzamide 
• 1604811-62-2 4-amino-N-(3-(5-cyano-4-(1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)benzamide 
• 1604811-60-0 4-amino-N-(3-(5-cyano-4-(1-(phenylsulfonyl)-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)benzamide 

Relevant academic research and scientific papers

Carbonyl Iron Powder: A Reagent for Nitro Group Reductions under Aqueous Micellar Catalysis Conditions

An especially mild, safe, efficient, and environmentally responsible reduction of aromatic and heteroaromatic nitro-group-containing educts is reported that utilizes very inexpensive carbonyl iron powder (CIP), a highly active commercial grade of iron powder. These reductions are conducted in the presence of nanomicelles composed of TPGS-750-M in water, a recyclable aqueous micellar reaction medium. This new technology also shows broad scope and scalability and presents opportunities for multistep one-pot sequences involving this reducing agent.

INHIBITORS OF CYCLIN-DEPENDENT KINASE 7 (CDK7)

The present invention provides novel compounds of Formula (I), and pharmaceutically acceptable salts, solvates, hydrates, polymorphs, co-crystals, tautomers, stereoisomers, isotopically labeled derivatives, prodrugs, and compositions thereof. Also provide

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same

Compounds are disclosed that have a formula represented by the following: The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of a variety of conditions in mammals including humans, including by way of non-limiting example, pain, inflammation, traumatic injury, and others.

MAKROTRICYCLIC AND MACROPENTACYCLIC DITOPIC RECEPTOR MOLECULES. SYNTHESIS, CRYSTAL STRUCTURE AND SUBSTRATE BINDING.

A macrocyclic (1), three nacropentacyclic (2a-c) and a macrobicyclic (3b) receptor molecules have been synthesized, via a particularly efficient route for (2b) and (2c).The crystal structures of (1), (2b) and (3b) have been determined and related to some